Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Indian J Exp Biol ; 2014 Aug; 52(8): 773-780
Article in English | IMSEAR | ID: sea-153758

ABSTRACT

A major impediment in chemotherapy of Tuberculosis (TB) is the persistence of M. tuberculosis in a latent or dormant state, possibly perpetuated by paucity of oxygen within the lung granuloma. Proteome analysis of the anaerobically persisting microbe could therefore provide novel targets for drugs against latent TB infection (LTBI). An Indian clinical isolate of M. tuberculosis was cultured under aerobic and anaerobic conditions following Wayne’s hypoxia model and its cytosolic proteins were resolved by two-dimensional gel electrophoresis (2DE). Peptide mass fingerprinting of 32 differentially expressed spots using MALDI TOF-TOF MS-MS resulted in identification of 23 proteins. Under the anaerobic culture conditions, expression of 12 of these proteins was highly suppressed (>2 fold reduction in spot volumes), with 4 of them (GrpE, CanB, MoxR1 and Eis) appearing as completely suppressed since corresponding spots were not detectable in the anaerobic sample. On the other hand, 4 proteins were highly expressed, with two of them (Wag31 and GroES) being uniquely expressed under anaerobic conditions. Suppression of Eis could make the anaerobically persisting bacilli susceptible to the aminoglycoside antibiotics which are known to be acetylated and inactivated by Eis. Although all 4 over-expressed proteins can be considered as putative drug targets for LTBI, Wag31 appears particularly interesting in view of its role in the cell wall biogenesis.


Subject(s)
Anaerobiosis , Antigens, Bacterial/biosynthesis , Bacterial Proteins/antagonists & inhibitors , Bacterial Proteins/biosynthesis , Cell Culture Techniques , Cytosol/metabolism , Gene Expression Regulation, Bacterial , Heat-Shock Proteins/antagonists & inhibitors , Heat-Shock Proteins/biosynthesis , Humans , Latent Tuberculosis/drug therapy , Latent Tuberculosis/microbiology , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/pathogenicity , Proteome , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2.
Experimental & Molecular Medicine ; : 87-92, 1998.
Article in English | WPRIM | ID: wpr-70154

ABSTRACT

MDR1 promoter has been shown to contain heat shock elements (HSE), and it has been reported that FM3A/M and P388/M MDR cells show a constitutively activated heat shock factor (HSF), suggesting that HSF might be an important target for reversing the multidrug resistance. Therefore, it was examined whether quercetin, which has been shown to interfere with the formation of the complex between HSE and HSF, and to downregulate the level of HSF1, can sensitize MDR cells against anticancer drugs by inhibition of HSF DNA-binding activity. In this study, quercetin appeared to inhibit the constitutive HSF DNA-binding activity and the sodium arsenite-induced HSF DNA-binding activity in the MDR cells. The basal and sodium arsenite-induced MDRCAT activities were remarkably suppressed by the treatment of quercetin. These results were well consistent with the finding that the treatment of quercetin decreased the expression level of P-gp, MDR1 gene product, in dose-dependent manner, and markedly increased the sensitivity of MDR cells to vincristine or vinblastine. These results suggest that quercetin can decrease the expression of P-gp via inhibition of HSF DNA-binding activity, and might be useful as a chemosensitizer in MDR cells.


Subject(s)
Mice , Animals , Antineoplastic Agents/pharmacology , Arsenites/pharmacology , Carcinoma/drug therapy , Drug Resistance, Multiple/physiology , Drug Resistance, Neoplasm/physiology , Heat-Shock Proteins/metabolism , Heat-Shock Proteins/drug effects , Heat-Shock Proteins/antagonists & inhibitors , Leukemia, Experimental/drug therapy , ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , ATP Binding Cassette Transporter, Subfamily B, Member 1/drug effects , Quercetin/pharmacology , Sodium Compounds/pharmacology , Tumor Cells, Cultured , Vinblastine/pharmacology , Vincristine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL